In cancer cells, cyclooxygenase 2 (COX-2) is a key regulator driving the synthesis of PGE2, which subsequently promotes oncogenesis through binding to its receptors; thus, targeting COX-2 has been generally employed in cancer therapies. This evidence concerns the gene PTGS2 and cancer.